KRT17 and cancer: As a downstream factor of the TGF‐β1‐/ERK1/2‐/MZF1 signalling pathway, KRT17 has been shown to promote metastasis through enabling the acquisition of tumour microenvironment related cancer stem cell (CSC) properties in cervical cancer.41